Carsten Brunn's most recent trade in Cartesian Therapeutics Inc was a trade of 23,766 Common Stock done at an average price of $6.8 . Disclosure was reported to the exchange on Jan. 6, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cartesian Therapeutics Inc | Carsten Brunn | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 6.82 per share. | 06 Jan 2026 | 23,766 | 323,530 (0%) | 0% | 6.8 | 162,077 | Common Stock |
| Cartesian Therapeutics Inc | Carsten Brunn | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 415,700 | 415,700 | - | - | Employee Stock Option (right to buy) | |
| Cartesian Therapeutics Inc | Carsten Brunn | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 143,200 | 347,296 (0%) | 0% | 0 | Common Stock | |
| Cartesian Therapeutics Inc | Carsten Brunn | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 16.83 per share. | 03 Jan 2025 | 8,708 | 204,096 (0%) | 0% | 16.8 | 146,575 | Common Stock |
| Cartesian Therapeutics Inc | Carsten Brunn | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 16.72 per share. | 03 Jan 2025 | 8,563 | 212,804 (0%) | 0% | 16.7 | 143,190 | Common Stock |
| Cartesian Therapeutics Inc | Carsten Brunn | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 169,100 | 169,100 | - | - | Employee Stock Option (right to buy) | |
| Cartesian Therapeutics Inc | Carsten Brunn | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 57,500 | 221,367 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 5,971,000 | 5,971,000 | - | - | Employee Stock Option (right to buy) | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 4,654,100 | 4,916,056 (5%) | 5% | 0 | Common Stock | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.13 per share. | 04 Jan 2023 | 27,549 | 799,534 (0%) | 0% | 1.1 | 31,232 | Common Stock |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.13 per share. | 04 Jan 2023 | 13,396 | 786,090 (0%) | 0% | 1.1 | 15,128 | Common Stock |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.12 per share. | 04 Jan 2023 | 77 | 786,013 (0%) | 0% | 1.1 | 86 | Common Stock |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.15 per share. | 04 Jan 2023 | 48 | 799,486 (0%) | 0% | 1.1 | 55 | Common Stock |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2023 | 1,275,000 | 1,275,000 | - | - | Employee Stock Option (right to buy) | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2023 | 282,800 | 827,083 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.33 per share. | 05 Dec 2022 | 4,522 | 544,283 (0%) | 0% | 1.3 | 6,014 | Common Stock |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 10,938 | 0 | - | - | Restricted Stock Units | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 10,938 | 548,805 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 10,937 | 545,327 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 10,937 | 10,938 | - | - | Restricted Stock Units | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.85 per share. | 01 Sep 2022 | 4,768 | 540,559 (0%) | 0% | 1.8 | 8,810 | Common Stock |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 10,938 | 21,875 | - | - | Restricted Stock Units | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 10,938 | 534,390 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 10,937 | 32,813 | - | - | Restricted Stock Units | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 10,937 | 528,895 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.81 per share. | 01 Mar 2022 | 5,443 | 523,452 (0%) | 0% | 1.8 | 9,863 | Common Stock |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.09 per share. | 05 Jan 2022 | 13,597 | 517,958 (0%) | 0% | 3.1 | 41,959 | Common Stock |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 1,056,100 | 1,056,100 | - | - | Employee Stock Option (right to buy) | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 226,300 | 531,555 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 2.99 per share. | 10 Dec 2021 | 17,196 | 305,255 (0%) | 0% | 3.0 | 51,363 | Common Stock |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2021 | 37,500 | 322,451 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2021 | 10,938 | 289,697 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2021 | 10,938 | 43,750 | - | - | Restricted Stock Units | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 2.96 per share. | 01 Dec 2021 | 4,746 | 284,951 (0%) | 0% | 3.0 | 14,065 | Common Stock |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.39 per share. | 13 Oct 2021 | 15,313 | 278,759 (0%) | 0% | 4.4 | 67,224 | Common Stock |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 37,500 | 294,072 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2021 | 163,000 | 163,000 | - | - | Employee Stock Option (right to buy) | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2021 | 27,200 | 256,572 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2021 | 10,937 | 54,688 | - | - | Restricted Stock Units | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2021 | 10,937 | 233,895 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.51 per share. | 01 Sep 2021 | 4,523 | 229,372 (0%) | 0% | 4.5 | 20,399 | Common Stock |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 10,938 | 227,764 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 10,938 | 65,625 | - | - | Restricted Stock Units | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.38 per share. | 01 Jun 2021 | 4,806 | 222,958 (0%) | 0% | 4.4 | 21,041 | Common Stock |